240 related articles for article (PubMed ID: 26356815)
1. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.
Duan R; Han L; Wang Q; Wei J; Chen L; Zhang J; Kang C; Wang L
Oncotarget; 2015 Sep; 6(29):27778-93. PubMed ID: 26356815
[TBL] [Abstract][Full Text] [Related]
2. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
Tong YQ; Liu B; Zheng HY; Gu J; Liu H; Li F; Tan BH; Hartman M; Song C; Li Y
Oncotarget; 2015 Sep; 6(28):25024-33. PubMed ID: 26317904
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
4. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
Li Y; Zhang X; Chen D; Ma C
Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells.
Han J; Shen X; Zhang Y; Wang S; Zhou L
Biosci Biotechnol Biochem; 2020 Jul; 84(7):1345-1352. PubMed ID: 32154763
[TBL] [Abstract][Full Text] [Related]
6. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin.
Xu A; Wang X; Luo J; Zhou M; Yi R; Huang T; Lin J; Wu Z; Xie C; Ding S; Zeng Y; Song Y
Cell Death Dis; 2021 Feb; 12(2):157. PubMed ID: 33542188
[TBL] [Abstract][Full Text] [Related]
8. Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer.
Wang Y; He B; Dong Y; He GJ; Qi XW; Li Y; Yang YF; Rao Y; Cen ZS; Han F; Ding J; Li JJ
Cancer Biomark; 2021; 31(3):239-254. PubMed ID: 33896818
[TBL] [Abstract][Full Text] [Related]
9. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
10. HOXA13 promotes colon cancer progression through β-catenin-dependent WNT pathway.
Gu Y; Gu J; Shen K; Zhou H; Hao J; Li F; Yu H; Chen Y; Li J; Li Y; Liang H; Dong Y
Exp Cell Res; 2020 Oct; 395(2):112238. PubMed ID: 32822724
[TBL] [Abstract][Full Text] [Related]
11. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
12. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
13. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
Ni H; Ji D; Li J; Zhao Z; Zuo J
Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
15. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
[TBL] [Abstract][Full Text] [Related]
16. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
Choi YJ; Baek GY; Park HR; Jo SK; Jung U
PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed homeobox B9 regulates oncogenic activities by transforming growth factor-β1 in gliomas.
Fang L; Xu Y; Zou L
Biochem Biophys Res Commun; 2014 Mar; 446(1):272-9. PubMed ID: 24582746
[TBL] [Abstract][Full Text] [Related]
18. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
19. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.
Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ
Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
